Leukocytoclastic vasculitis: A rare manifestation of propylthiouracil hypersensitivity

Medical Principles and Practice

Volumn 14, Issue 5, 2005, Pages 366-369

  Erem, Cihangir ^a,c   Yücel, Yusuf ^b   Yaşar, Ziya ^b   Reis, Abdülkadir ^b   Kocak, Mustafa ^a   Hacihasanoglu, Arif ^a  

^a Division of Endocrinology and Metabolism   (Turkey)

^b KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^c KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Cutaneous vasculitis; Propylthiouracil therapy; Side effect

Indexed keywords

PROPYLTHIOURACIL; THIAMAZOLE;

AGED; ANAMNESIS; ARTICLE; BUTTOCK; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC TEST; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EUTHYROIDISM; FEMALE; HUMAN; HYPERTHYROIDISM; LABORATORY TEST; LEG; LEUKOCYTOCLASTIC VASCULITIS; MEDICAL ASSESSMENT; PATIENT REFERRAL; SKIN BIOPSY; SKIN DEFECT; THYROID ADENOMA;

ADENOMA; AGED; ANTITHYROID AGENTS; DIAGNOSIS, DIFFERENTIAL; EXANTHEMA; FEMALE; GOITER, NODULAR; HUMANS; HYPERTHYROIDISM; METHIMAZOLE; PROPYLTHIOURACIL; VASCULITIS, HYPERSENSITIVITY;

EID: 23844455214     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086938     Document Type: Article

References (12)

1. Cooper DS: Antithyroid drugs. N Engl J Med 1984;311:1353-1362.
2. D'Cruz D, Chesser AMS, Lightowler C, Comer M, Hurst MJ, Baker LRI, Raine AEG: Case report: antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with antithyroid drug treatment. Br J Rheumatol 1995;34:1090-1091.
3. Gammeltoft M, Kristensen JK: Propylthiouracil-induced cutaneous vasculitis. Acta Derm Venereol 1982;62:171-173.
4. Chastain MA, Russo GG, Boh EE, Chastain JB, Falabella A, Millikan LE: Propylthiouracil hypersensitivity: report of two patients with vasculitis and review of the literature. J Am Acad Dermatol 1999;41:757-764.
5. Vasily DB, Tyler WB: Propylthiouracil-induced cutaneous vasculitis. JAMA 1980;243:458-461.
6. Harper L, Cockwell P, Savage COS: Case of propylthiouracil-induced ANCA associated small vessel vasculitis. Nephrol Dial Transplant 1998;13:455-458.
7. Kitahara T, Hiromura K, Maezawa A, Ono K, Narahara N, Yano S, Naruse T, Takenouchi K, Yasumoto Y: Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA): review of literature. Clin Nephrol 1997;47:336-340.
8. Wolf D, Ben-Yehuda A, Okon E, Naparstek Y: Nodular vasculitis associated with propylthiouracil therapy. Cutis 1992;49:253-255.
9. McCormick RV: Periarteritis occurring during propylthiouracil therapy. JAMA 1950;144:1453-1454.
10. Griswolg WR, Mendoza SA, Johnston W, Nichols S: Vasculitis associated with propylthiouracil: evidence for immune complex pathogenesis and response to therapy. West J Med 1978;128:543-546.
11. Yarman S, Sandalci O, Tanakol R, Azizlerli H, Oguz H, Alagol F: Propylthiouracil-induced cutaneous vasculitis. Int J Clin Pharmacol Ther 1997;35:282-286.
12. Hori Y, Arizona K, Hara S, Kawai R, Hara M, Yamada A: Antineutrophil cytoplasmic antibody-positive crescentic glomeralonephritis associated with thimazole therapy. Nephron 1996;74:734-735.